Colorectal cancer patients before resection of hepatic metastases. Impact of 18F-FDG PET on detecting extrahepatic disease

NuklearMedizin

Volumn 43, Issue 4, 2004, Pages 135-140

  Rosa, Frank ^a,c   Meimarakis, G ^a   Stahl, A ^b   Bumm, R ^b   Hahn, K ^a   Tatsch, K ^a   Dresel, St ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Colorectal cancer; Extrahepatic disease; FDG; Hepatic metastases; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; GERMANY; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; LABORATORY DIAGNOSIS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY;

EID: 4344627474     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625317     Document Type: Article

References (25)

1. 18F fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 1994; 81: 1666-70.
2. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231: 743-51.
3. Delbeke D, Patton JA, Martin WH et al. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders. J Nucl Med 1999; 40: 110-7.
4. 18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer. Nuklearmedizin 2003; 42: 145-56.
5. Flamen P, Stroobants S, van Cutsen E et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D- glucose in recurrent colorectal cancer. J Clin Oncol 1999; 17: 894-901.
6. Fong Y, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-46.
7. 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999; 178: 282-7.
8. Fortner JG, Silva JS, Golbey RB et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984; 199: 306-16.
9. Gayowski TJ, Iwatsuki S, Madariaga JR et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994; 116: 703-10; discussion 710-1.
10. Greenway B. Hepatic metastases from colorectal cancer: resection or not. Br J Surg 1988; 75: 513-9.
11. Huebner RH, Park KC, Shepherd JE et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41: 1177-89.
12. 18F-FDG- positron emission tomography for decision making in colorectal cancer recurrences. Langenbeck's Arch Surg 2000; 385: 129-34.
13. 18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996; 131: 703-7.
14. 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. J Nucl Med 2001; 42: 586-90.
15. Minagawa M, Makuuchi M, Torzilli G et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231: 487-99.
16. Ogunbiyi OA, Flanagan FL, Dehdashti F et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 1997; 4: 613-20.
17. Robinson BJ, Rice TW, Strong SA et al. Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer? J Thorac Cardiovasc Surg 1999; 117: 66-75; discussion 75-66.
18. 18F fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002; 20: 388-95.
19. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990; 77: 1241-6.
20. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989; 210: 127-38.
21. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996; 23: 1409-15.
22. Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990; 174: 621-6.
23. 18F fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999; 134: 503-11.
24. Vauthey JN. Liver imaging. A surgeon's perspective. Radiol Clin North Am 1998; 36: 445-57.
25. Vitola J, Delbeke D. Positron emission tomography for evaluation of colorectal carcinoma. Semin Roentgenol 2002; 37: 118-28.